Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0002026600-26-000002

Chief Technical Officer acquired 38,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tsai Philip · Chief Technical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-23 Grant or award : show line 1 in the form +38,250 81,550 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-23 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +76,500 76,500 D
Loading xslF345X06/form4-07272026_040711.xml…